Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 7Neoplasms 6Breast Neoplasms 6Vomiting 2Solid Tumors 2Skin Neoplasms 2Neoplasm Metastasis 2Melanoma 2Diabetes Mellitus 2Weight Gain 1Venous Thromboembolism 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1Skin Toxicity 1Renal Insufficiency 1Prostatic Neoplasms 1Primary Myelofibrosis 1Premature Birth 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pre-Eclampsia 1Polycythemia Vera 1Parathyroid Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Nausea 1Myeloproliferative Disorders 1Multiple Myeloma 1

Interventions

Fulvestrant 5Anastrozole 4Letrozole 3Docetaxel 2Dasatinib 2vandetanib 1sonidegib 1ribociclib 1pembrolizumab 1palbociclib 1olaparib 1irinotecan sucrosofate 1exemestane 1cediranib 1XMT-1522 1Vorinostat 1Tablets 1Ritonavir 1Population Groups 1Paclitaxel 1Moxifloxacin 1Itraconazole 1Histone Deacetylase Inhibitors 1Gemcitabine 1FCN-437c 1Everolimus 1Electroporation 1Cryosurgery 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Breast Cancer × Tablets × Clear all
NCT03405168 2018-11-16

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Sun Yat-sen University

Phase 2 Completed
35 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡